Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study

  1. Nooka, A.K.
  2. Rodriguez, C.
  3. Mateos, M.V.
  4. Manier, S.
  5. Chastain, K.
  6. Banerjee, A.
  7. Kobos, R.
  8. Qi, K.
  9. Verona, R.
  10. Doyle, M.
  11. Martin, T.G.
  12. van de Donk, N.W.C.J.
Aldizkaria:
Cancer

ISSN: 1097-0142,  0008-543X

Argitalpen urtea: 2024

Alea: 130

Zenbakia: 6

Orrialdeak: 886-900

Mota: Artikulua

DOI: 10.1002/CNCR.35107 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus